ABSTRACT

Objective:

Patients with coronavirus disease-2019 (COVID-19) pneumonia have high hospitalization, intensive care unit (ICU) need and mortality rates. In this study, we aimed to follow-up the need of intensive care and mortality rates in patients with COVID-19 pneumonia with red blood cell distribution width (RDW) value because it is a cheap and easyl accesible marker.

Materials and Methods:

Patients with severe COVID-19 pneumonia hospitalized in the ICU (n=162), patients with mild COVID-19 pneumonia hospitalized in the ward (n=163), and healthy individuals (healthcare workers without a history of COVID-19 pneumonia) (n=162) were included in the study. Hemoglobin (HGB), white blood cell (WBC), red blood cell and RDW values were determined from the first admission hemogram and their effect on mortality was evaluated retrospectively.

Results:

When the groups were compared according to mortality, the average age of the patients who died of COVID-19 was found to be higher. According to the age-adjusted model analysis, in our study, in which the risk factors affecting mortality were investigated, RDW value was not found to be effective on mortality. Also age, HGB, WBC and COVID-19 positivity were found to be statistically significant parameters on mortality.

Conclusion:

Rapid and easily accessible markers are needed to reduce the follow-up of patients with severe COVID-19 pneumonia with high mortality in the ICU. In our study, while the effect of hematological parameters such as WBC and HGB on mortality was significant, it was observed that the RDW value did not affect mortality. Prospective randomized studies are needed in this regard.

Keywords: COVID-19 pneumonia, erythrocyte distribution width, intensive care unit, mortality

References

Foy BH, Carlson JCT, Reinertsen E, Padros I Valls R, Pallares Lopez R, et al. Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection. JAMA Netw Open 2020;3:e2022058.

Bahrikarehmi L, Fallah A, Yiğit S. Development of SARS-COV-2. Black Sea Journal of Health Science 2020;3:94-101.

Martinez-Urbistondo M, Mora-Vargas A, Expósito-Palomo E, Castejón R, Citores MJ, Rosado S, et al. Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients. Mediators Inflamm 2020;2020:2914275.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323:1574-81.

Gong J, Ou J, Qiu X, Jie Y, Chen Y, Yuan L, et al. A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China. Clin Infect Dis 2020;71:833-40.

Liang J, Nong S, Jiang L, Chi X, Bi D, Cao J, et al. Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment. J Clin Lab Anal 2021;35:e23609.

Mei Y, Weinberg SE, Zhao L, Frink A, Qi C, Behdad A, et al. Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza. EClinicalMedicine 2020;26:100475.

Lippi G, Henry BM, Sanchis-Gomar F. Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019. Acta Haematol 2021;144:360-4.

Eser K, Sezer E, Erçolak V. Eritrosit Dağılım Genişliği (RDW): Metastatik Kolorektal Kanserde Prognoz Belirleyici Olarak Kullanımı. Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi 2019;9:66-72.

Fernandez R, Cano S, Catalan I, Rubio O, Subira C, Masclans J, et al. High red blood cell distribution width as a marker of hospital mortality after ICU discharge: a cohort study. J Intensive Care 2018;6:74.

Duran M, Uludağ Ö. Can Platelet Count and Mean Platelet Volume and Red Cell Distribution Width Be Used as a Prognostic Factor for Mortality in Intensive Care Unit? Cureus 2020;12:e11630.

Karampitsakos T, Akinosoglou K, Papaioannou O, Panou V, Koromilias A, Bakakos P, et al. Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study. Front Med (Lausanne) 2020;7:616292.

Hornick A, Tashtish N, Osnard M, Shah B, Bradigan A, Albar Z, et al. Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults. Pathog Immun 2020;5:312-26.

Fava C, Cattazzo F, Hu ZD, Lippi G, Montagnana M. The role of red blood cell distribution width (RDW) in cardiovascular risk assessment: useful or hype? Ann Transl Med 2019;7:581.

Hu ZD, Lippi G, Montagnana M. Diagnostic and prognostic value of red blood cell distribution width in sepsis: A narrative review. Clin Biochem 2020;77:1-6.

Martínez-Velilla N, Ibáñez B, Cambra K, Alonso-Renedo J. Red blood cell distribution width, multimorbidity, and the risk of death in hospitalized older patients. Age (Dordr) 2012;34:717-23.

Bazick HS, Chang D, Mahadevappa K, Gibbons FK, Christopher KB. Red cell distribution width and all-cause mortality in critically ill patients. Crit Care Med 2011;39:1913-21.

Safdar SA, Modi T, Sriramulu LD, Shaaban H, Sison R, Modi V, et al. The Role of Red Cell Distribution Width as a Predictor of Mortality for Critically Ill Patients in an Inner-city Hospital. J Nat Sci Biol Med 2017;8:154-8.

TC. Sağlık Bakanlığı COVID-19 (SARS-COV-2 Enfeksiyonu) Enfeksiyonunun Tanı ve Tedavisi Kılavuzu Bilimsel Danışma Kurulu Çalışması.27.Mayıs.2021

Lorente L, Martín MM, Argueso M, Solé-Violán J, Perez A, Marcos Y Ramos JA, et al. Association between red blood cell distribution width and mortality of COVID-19 patients. Anaesth Crit Care Pain Med 2021;40:100777.

Lin S, Mao W, Zou Q, Lu S, Zheng S. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection. J Clin Lab Anal 2021;35:e23604.

Sharma D, Dayama A, Banerjee S, Bhandhari S, Chatterjee A, Chatterjee D. To Study the Role of Absolute Lymphocyte Count and RDW in COVID 19 Patients and their Association with Appearance of Symptoms and Severity. J Assoc Physicians India 2020;68:39-42.

Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19 Accessed: 11-february-2022.

Wang F, Pan W, Pan S, Ge J, Wang S, Chen M. Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med 2011;43:40-6.

Owoicho O, Tapela K, Olwal CO, Djomkam Zune AL, Nganyewo NN, Quaye O. Red blood cell distribution width as a prognostic biomarker for viral infections: prospects and challenges. Biomark Med 2022;16:41-50.

Lanini S, Montaldo C, Nicastri E, Vairo F, Agrati C, Petrosillo N, et al. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One 2020;15:e0244129.

Taneri PE, Gómez-Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa-Díaz ZM,et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol 2020;35:763-73.

Satici C, Demirkol MA, Sargin Altunok E, Gursoy B, Alkan M, Kamat S, et al. Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19. Int J Infect Dis 2020;98:84-9.

Wang C, Zhang H, Cao X, Deng R, Ye Y, Fu Z, et al. Red cell distribution width (RDW): a prognostic indicator of severe COVID-19. Ann Transl Med 2020;8:1230.

The Relationship of Erythrocyte Distribution Width Value with Mortality in Patients with COVID-19 Pneumonia

ABSTRACT

References